Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FSCN2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | MLXIP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PKHD1L1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | FAM159B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | ZNF195 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | FRRS1L | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | SLCO5A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | PLEC | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | HERC4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |